Booking inPune - 411005
Cart
Also Known asPSA - Prostate-Specific Antigen Level
No fasting required
Reports in 24 hours
Booked 1000+ times
For ages 18-99 years
Male
Report Format - Digital
FULFILLED BY
Healthians₹252
The PSA (Prostate-Specific Antigen) Total Test is a blood test that evaluates PSA levels in the bloodstream. PSA is a protein that is generated by prostate gland cells. This test is required to determine the existence of PSA and its levels for various medical purposes.
| Test Name | PSA-total Prostate Specific Antigen, total Test in Sayan |
| Collection Type | Home Visit, Lab Visit |
| Provider Name | Healthians+12 |
| Provider Address | Sayan |
| Also Known as | PSA - Prostate-Specific Antigen Level |
| Booked for | 1000+ times |
| Report time | 24 hrs |
| Preparation required. | No fasting required |
| Cost | ₹252 |
The test is widely used as a screening tool for prostate cancer, particularly in males aged 50 and older.
Elevated PSA values may suggest the existence of prostate cancer.
Monitoring Prostate Cancer: The test aids in monitoring the success of treatment and tracking cancer progression.
To assess prostate health and investigate conditions like enlargement of the prostate gland; Prostatitis (inflammation of the prostate gland).
Men aged 50 and older.
Men who are at higher risk due to factors such as family history or ethnicity
Individuals experiencing symptoms associated with prostate cancer, such as, Urinary problems; Pelvic pain; Blood in the urine or semen.
No special precaution required
The cost of a Psa-total Prostate Specific Antigen, Total Test in Sayan starts from ₹252, with options for home sample collection or lab visits depending on the provider. Please check the table below for a detailed comparison of labs and their prices.
Providers
Collection Type
Price
Book
| Healthians | Home Collection | ₹252 | |
| Redcliffe Labs | Home Collection | ₹800 | |
| Thyrocare | Home Collection | ₹647 | |
| Sterling Accuris Wellness Pvt Ltd | Lab Visit | ₹700 | |
| Vrudam Institute Of Medical Science | Lab Visit | ₹560 | |
| UNIVERSAL SUPERSPECIALITY HOSPITAL LIMITED | Lab Visit | ₹1250 | |
| Neuberg Diagnostics | Lab Visit | ₹830 | |
| Bharat Pathology Laboratory | Lab Visit | ₹650 | |
| LIFE LINE PATHOLOGY LABARATERY | Lab Visit | ₹500 | |
| Aspira Pathlab and Diagnostics Limited | Lab Visit | ₹800 | |
| Gunjan Lab LLP | Lab Visit | ₹650 | |
| Patel Multispeciality Hospital & ICU | Lab Visit | ₹750 | |
| Orange Multispecialty Hospital & ICU | Lab Visit | ₹600 |
Book a test at your preferred lab by selecting home sample collection
Get your sample collected by the lab technician at your home
Receive your lab reports within 24 hours over email
What level of PSA is alarming?
Generally, a PSA (prostate-specific antigen) level above 4.0 ng/mL is considered elevated and may be concerning for prostate issues. However, interpreting PSA levels depends on various factors, including age, individual risk factors, and medical history. It is essential to consult with your doctor, who will evaluate the PSA level in a thorough clinical assessment to determine the appropriate course of action.
How is high PSA treated?
Treatment for high PSA levels depends on the underlying cause. If elevated PSA is due to benign conditions like prostate enlargement, your doctor might recommend lifestyle changes, medications, or procedures to manage the condition. If the high PSA indicates prostate cancer, further diagnostic tests, such as a biopsy, may be performed to confirm the diagnosis. Your doctor will finalize the treatment options for prostate cancer, which may include surgery, radiation therapy, hormone therapy, or active surveillance tailored to the specific stage and characteristics of the cancer.
What is the difference between total PSA and FREE PSA?
Total PSA refers to the overall level of prostate-specific antigen in the bloodstream, including both bound and unbound forms. Free PSA specifically refers to the unbound or non-complexed PSA in the blood. The ratio of free PSA to total PSA can provide additional information to differentiate between benign prostate conditions and prostate cancer.